Latest Industry Insights

This article discusses how library-based approaches in quantitative proteomics can increase the sensitivity and accuracy of such detection systems.

To learn more about the Pioneer Antibody Discovery Platform and its potential impact on drug discovery and development, we spoke to Dr. John Cardone.

This article overviews the science behind the potential use of RRx-001as a “radiation buster” with anti-inflammatory and anti-free radical properties to prevent or reduce both GI-ARS and H-ARS.

We speak with Dr. Niall Martin, CEO of Artios Pharma, to learn more about the development of drugs to target the DNA damage response pathway in cancer.

In this opinion piece, Francois Rieger discusses why reverse mergers are the way forward for advanced therapies.

From increasing trial diversity to using plants to manufacture drugs, the experts weigh in.

In this article, we will discuss how innovative HPLC with charged aerosol detection technology can tackle common analytical challenges, allowing robust characterization of the composition of the lipid nanoparticles in the formulation and accurate determination of impurities at the required regulatory levels.

To find out more about the Taiwan Precision Medicine Initiative and its aim to implement a sustainable precision health ecosystem in Taiwan, we spoke to Dr. Pui-Yan Kwok, leader of the initiative.

The development of the 7500 LC-MS system from SCIEX is bringing new levels of analytical sensitivity to researchers. To find out more about the system and the applications that could benefit, we spoke to Jack Steed, a technical specialist from SCIEX.

We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.